Search
Now showing items 1-2 of 2
Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab (vol 9, pg E36, 2009)
Wierda, William et al. (2010)
Wissenschaftlicher Artikel
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
Wierda, William G. et al. (2010)
Wissenschaftlicher Artikel